MedPath

A study to develop a novel ophthalmic testing method in patients with cystinosis

Phase 3
Recruiting
Conditions
Cystinosis
D003554
Registration Number
JPRN-jRCTs031220490
Lead Sponsor
Yamamoto Yuuka
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
6
Inclusion Criteria

Patients with cystinosis who meet the following criteria
1) Patients with presence of corneal cystine crystal deposits assessed during ophthalmic examination
2) Patients who have ability to or intend to comply with the 4 times daily instillation regimen
3) Patients who are judged by the principal investigator or sub-investigator to be appropriate for inclusion in the study.
4) Patients who have given written consent to participate in the research in person.
5) Patients who are at least 18 years of age at the time consent is obtained

Exclusion Criteria

1) Patients who are obviously suffering from a serious acute disease
2) Patients with a history of hypersensitivity to the active ingredients or additives of the test drug
3) Pregnant or possibly pregnant or lactating women
4) Persons who are judged by the principal investigator to be inappropriate for inclusion in the study

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
uminance waveform analysis (LWA) by using AS-OCT
Secondary Outcome Measures
NameTimeMethod
Photophobia rated by investigators<br>Photophobia rated by patients
© Copyright 2025. All Rights Reserved by MedPath